Objectives: The aim of this study was to evaluate the impact of qnrA1, qnrB1 and qnrS1 on the in vivo efficacies of ciprofloxacin and levofloxacin in an experimental model of pneumonia caused by Escherichia coli.
Methods: Two isogenic groups of E. coli transformants, based on two ATCC 25922 strains, with or without the GyrA mutation Ser83Leu, and carrying qnrA1, qnrB1 or qnrS1, were used in an experimental pneumonia model. The efficacies of ciprofloxacin (40 mg/kg/day) and levofloxacin (50 and 150 mg/kg/day) were evaluated.
Results: For the pneumonia caused by the parental strains lacking qnr genes, both fluoroquinolones significantly (P<0.05) reduced the bacterial lung concentration by >7 log10 cfu/g against E. coli ATCC/pBK and between 5.09 and 6.34 log10 cfu/g against E. coli ATCC-S83L/pBK. The presence of any qnr genes in the strains of both isogenic groups diminished the reduction of bacterial lung concentration with any therapy (P<0.05). Furthermore, all therapeutic schemes reduced the percentage of positive blood cultures in both isogenic groups (P<0.05). Finally, the survival results suggest a higher mortality with the strains expressing qnr genes.
Conclusions: The presence of qnrA1, qnrB1 and qnrS1 in E. coli reduced the efficacy of ciprofloxacin and levofloxacin in a murine pneumonia model.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jac/dkt063 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of Beta-Lactamase and Fluoroquinolone Resistance Determinants in , and Isolates from a Tertiary Hospital in Yola, Nigeria.
Trop Med Infect Dis
November 2023
Department of Medical Microbiology, Parasitology and Immunology, Modibbo Adama University Teaching Hospital, Yola 640001, Adamawa State, Nigeria.
Article Synopsis
- * Whole genome sequencing revealed increased diversity in resistance strains in the later period, with a significant presence of genes responsible for extended-spectrum beta-lactamase (ESBL) and high fluoroquinolone resistance, showing a decrease from 77% to 47.8%.
- * The study highlights the worrying trend of multidrug-resistant bacteria and underscores the need for ongoing monitoring to effectively manage and contain antimicrobial resistance in Nigeria.
High Plasticity of Multi-Drug Resistant ST258 .
Microb Drug Resist
August 2021
Laboratorio de Microbiología Clínica, Departamento de Bioquímica Clínica, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
Carbapenemase production in Enterobacterales clinical isolates is a global threat. Multi-drug resistant harboring carbapenemases are a major concern among the hospital settings in Latin America. The aim of this study was to analyze the genetic relatedness between three isolates of recovered from one patient in the same bacteriological round on the same day, which exhibited different susceptibility profiles to carbapenems (CP) and to colistin (Col).
View Article and Find Full Text PDFCharacterization of uropathogenic ESBL-producing Escherichia coli isolated from hospitalized patients in western Algeria.
J Infect Dev Ctries
April 2019
Laboratory of Applied Microbiology in Food, Biomedical and Environment, Aboubekr Belkaïd University, Tlemcen, Algeria.
Introduction: The aim of this study is to assess the prevalence and molecular characterization of uropathogenic Extended spectrum β-lactamases (ESBLs) producing Escherichia coli.
Methodology: During 3 years, all hospitalized patients at the University-affiliated hospital of Tlemcen and presenting urinary tract infections caused by E. coli were considered as potential study participants.
Quinolone resistance mechanisms among third-generation cephalosporin resistant isolates of spp. in a Bulgarian university hospital.
Infect Drug Resist
May 2019
Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.
There have been no reports in Bulgaria about quinolone resistance determinants among spp. To investigate plasmid and chromosomal quinolone resistance rates among 175 third-generation cephalosporin resistant spp. isolates (167 complex and eight isolates) collected at a university hospital in Varna, Bulgaria, as well as to reveal their association with ESBL/AmpC production and a carriage of specific plasmid replicon types.
View Article and Find Full Text PDFMultiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in ST11 High-Risk Clone and Recently Emerging ST307 Clone.
Front Microbiol
February 2019
Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary.
Article Synopsis
- International high-risk clones of pathogens are causing significant treatment challenges in hospitals due to their increased diversity and spread of antimicrobial resistance genes.
- A study conducted in Hungary focused on fluoroquinolone resistance in extended-spectrum beta-lactamase (ESBL)-producing strains and used whole-genome sequencing and molecular typing to analyze specific bacterial strains.
- Findings revealed different strains had varying resistance mechanisms, with the ST307 clone identified for the first time in Hungary, indicating its potential as an emerging high-risk pathogen globally.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!